Navigation Links
Pharmspective Announces the Release of ClearView™ - a New Health Care Reform Knowledge Management Web Application for the Biopharma Industry
Date:3/6/2012

NEW YORK, March 6, 2012 /PRNewswire/ -- Pharmspective, LLC today announced the release of its first knowledge management application - ClearView™ - specifically developed to analyze provisions in the health care reform law and their impact on key pharma customer decision makers who influence product adoption. Pharmspective, LLC is a Specialty Therapeutics market research firm providing knowledge management applications to the pharmaceutical industry.

Pharmspective's new ClearView™ PC and iPad-compatible web app is a subscription database housing over 400 key provisions of the health care reform legislation. The ClearView™ interactive platform will help Pharmspective subscribers assess the impact of key provisions of the legislation on pharmaceutical brands by providing up-to-date perspectives from published opinions and third-party points of view.

ClearView™: A Powerful Planning and Strategic Decision Making Platform
ClearView™ is updated regularly with the most recent articles, interpretations, and potential commercial-impact scenarios related to the legislation.  The platform provides a number of distinct features:

  • Description of key provisions
  • Keyword search capability
  • News Updates
  • Scenario function – giving ClearView™ users the ability to input their own scenario assessments of key provisions in the legislation
  • Report function
  • Diagnostic Quiz for Corporate Training

"We're really proud of the cutting-edge user experience that our new ClearView™ app provides," said Karl Kessler, Chief Technology Officer. "ClearView™ translates the healthcare reform legislation through a dynamic, intuitive web app that lets the user browse and search the legislation, link to news articles and background material on the web, and collaborate with planning teams to assess and define the commercial impact of the law on pharma brands."

"The pharmaceutical industry is inundated with information about Healthcare Reform today and is in need of  solutions that navigate through its legislative complexity. We believe ClearView™ will be embraced as an invaluable planning tool that will facilitate thinking about how health care reform will impact the commercialization of pharma products today and in the future," stated Stephen Reid, Managing Partner and Co-Founder.

About Pharmspective: Pharmspective, LLC (www.pharmspective.com) is a Specialty Therapeutics market research firm providing commercial insights and knowledge management applications for the biopharmaceutical industry. The company is uniquely focused on understanding the buying process for specialty therapeutics through syndicated market research studies examining clinical decision-making, drug acquisition, access and reimbursement, and patient administration for specialty therapeutics in autoimmune diseases (rheumatoid arthritis, psoriasis, multiple sclerosis, Crohn's/UC, lupus) and oncology. Pharmspective's proprietary knowledge management applications create a superior user experience that broadens client understanding of and perspective on research findings. Pharmspective™ is a trademark of Pharmspective LLC. The company maintains offices in New York City and St. Louis, MO.

Contact: Jennifer Strathmann Tel: 314-814-2729 x1002 jennifer.strathmann@pharmspective.com


'/>"/>
SOURCE Pharmspective, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Jazz Pharmaceuticals Announces Public Offering of Ordinary Shares by Selling Shareholders
2. PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
3. Varian Medical Systems Announces Agreement to Acquire InfiMed, Inc.
4. HASCO Medical Announces its Fourth Acquisition in the Last 9 Months With the Purchase of Ride-Away
5. Sono-Tek Announces Record Year End Results
6. Medical Care Technologies Inc. Announces Adjournment of Special Meeting
7. ECLINSO Announces Partnership with XClinical
8. ConvaTec Announces Acquisition of SureCalm Healthcare
9. Law Office of Brodsky & Smith, LLC Announces Investigation of Globus Medical, Inc.
10. Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan
11. Qforma Announces New Executive Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... DIEGO , Dec. 6, 2016  Arcturus ... RNA medicines company, announced today that it entered ... develop RNA-based therapeutics for the treatment of NASH ... wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer ... "Given Takeda,s long-standing commitment to and expertise ...
(Date:12/6/2016)... , Dec. 6, 2016  Regulus Therapeutics Inc. ... leading the discovery and development of innovative medicines ... candidates at its R&D day, held in ... RGLS5040, is an anti-miR targeting microRNA-27 (miR-27) for ... RGLS4326, is an anti-miR targeting microRNA-17 (miR-17) for ...
(Date:12/6/2016)... new study released today by the Alliance for Integrity ... Pricing Program will continue to expand at an unprecedented rate ... $23 billion in total purchases at the 340B price. This ... B drug reimbursement purchases over the next five years.      ... data on total drug purchases through 340B from 2005 to ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... ... It is vital for any lab to secure funding, and the best ... Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline analysis and ... a GLP (Good Laboratory Practice) fashion. , With features designed to simplify life in ...
(Date:12/7/2016)... San Fernando Valley, CA (PRWEB) , ... December 07, 2016 , ... ... Sculptra can be used in several ways to restore a more youthful appearance to ... doctors , now offer Sculptra, along with a variety of other treatments, to rejuvenate ...
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward ... comments on social media that offer a rare glimpse into the mind of those ... and New York Times bestselling author, has described people with ADHD as having “Ferrari ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in the blood associated ... appearing online in the journal Radiology. , Heart disease and brain disease exact a ... the rapidly aging population. Damage to both organs often occurs at a subclinical stage, ...
(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes and ... around the nation. What do they have in common? All have been affected by ... new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. , ...
Breaking Medicine News(10 mins):